Profile for Argentina Patent: 042543

US Patent Family Members and Approved Drugs for Argentina Patent: 042543

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
7,863,287	Feb 28, 2027	Haleon Us Holdings	ADVIL ALLERGY SINUS	chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR042543

---

Introduction

Patent AR042543 pertains to a specific pharmaceutical invention filed and granted within Argentina’s patent system. This patent's scope and claims directly influence its commercialization, licensing, and enforcement potential within Argentina and potentially in other jurisdictions with similar patent protection standards. A thorough examination of this patent’s scope, claims, and overall patent landscape offers crucial insights for stakeholders, including pharmaceutical companies, generic manufacturers, legal entities, and investors.

---

Background and Context

Argentina’s patent system, governed by the Argentine Patent Law (Law 24,481), aligns with international standards, including adherence to TRIPS obligations. Pharmaceutical patents are granted for inventions that demonstrate novelty, inventive step, and industrial applicability. The patent landscape in Argentina shows steady growth, with many patents focusing on active pharmaceutical ingredients (APIs), formulations, and delivery systems.

The subject patent, AR042543, appears to fit within this landscape, likely involving a novel formulation, compound, or process. To contextualize its significance, it is crucial to analyze its claims’ scope and compare it with prior art and related patents.

---

Patent Scope and Claims Analysis

1. Summary of the Patent Content

While an official full-text transcript is needed for precise detail, publicly available patent records or summaries suggest that AR042543 focuses on a specific pharmaceutical compound or formulation. Such patents typically encompass:

• The chemical composition or active ingredient.
• The method of manufacturing or formulation process.
• Specific use or therapeutic application.
• Delivery mechanisms or delivery systems.

Assuming this patent aims to protect a novel pharmaceutical formulation or compound:

2. Main Claims Overview

Patent claims define the legal scope of protection and are critical in determining the patent’s strength and enforceability. They usually fall into two categories:

• Independent Claims: Broadest claims defining the core invention.
• Dependent Claims: Narrower claims that add specific limitations or embodiments.

Example (hypothetical):
Independent Claim: "A pharmaceutical composition comprising a therapeutically effective amount of compound X stabilized in a carrier Y, useful for treating disease Z."

Dependent Claim: "The composition of claim 1, wherein compound X is in a crystalline form exhibiting a specific polymorph."

Analysis:
The breadth of the independent claim indicates the scope of protection. If broad, it could cover various formulations of the compound or method of use, providing strong exclusivity. Narrow dependent claims specify particular embodiments, aiding targeted enforcement.

3. Claim Language and Limitations

Precision in patent claim language greatly influences scope. Limitations such as specific chemical structures, concentration ranges, or process steps can restrict or expand protection.

• Structural Claims: Cover specific molecular structures or chemical modifications.
• Method Claims: Cover manufacturing processes or therapeutic methods.
• Use Claims: Cover specific medical indications.

In the Argentine patent context, claim scope must balance breadth with novelty and inventive step requirements to withstand legal challenges and potential invalidation.

---

Patent Landscape and Prior Art Considerations

1. Overlap with Existing Patents

The patent landscape surrounding AR042543 likely includes:

• Other patents filed domestically and internationally involving similar compounds or formulations.
• Prior art documents such as published applications, scientific literature, or existing patents that disclose similar inventions.

A thorough patent search indicates whether AR042543 introduces a pioneering invention or a minor modification. Overlapping prior art can limit claim scope or risk invalidation.

2. Novelty and Inventiveness

Argentine patent examiners assess:

• Novelty: The invention must not be disclosed publicly before the filing date.
• Inventive Step: The invention must not be obvious to a person skilled in the field.

If prior art discloses similar compounds or formulations, AR042543 would need to demonstrate distinctive features or unexpected advantages to merit patentability.

3. Patent Family and Filing Strategies

AR042543’s patent family status indicates whether related applications have been filed internationally, beneficial for protecting the invention globally. Frequently, pharmaceutical patents pursue filings via PCT routes to extend protection.

In the Argentine landscape, filing trends suggest a focus on both local inventive contributions and strategic international protection.

---

Patent Enforcement and Lifecycle in Argentina

Once granted, AR042543 offers a protective term of 20 years from the filing date, subject to maintenance fees. Its enforceability depends on:

• Clear claim definitions.
• The existence of infringing products or processes.
• The strength of the patent’s validity against prior art.

Legal challenges can arise from generic manufacturers seeking to invalidate or sublicense the patent, especially if prior art surfaces or if the patent’s scope is contested.

---

Implications for Industry Stakeholders

• Innovators: Can leverage the scope to protect key formulations or processes, encouraging R&D investments.
• Generics: Must analyze claim scope to identify potential infringement risks or design around strategies.
• Regulators: Use patent landscape analysis for market authorization decisions.

---

Conclusion and Strategic Outlook

Patent AR042543 embodies a critical piece of Argentina’s pharmaceutical innovation landscape. Its scope and claims define the competitiveness and exclusivity potential within the local market. Stakeholders must scrutinize claim language for validity, novelty, and possible overlaps to inform licensing, enforcement, or research investments.

---

Key Takeaways

• Scope Clarity: Precise, well-drafted claims maximize legal enforceability and market exclusivity.
• Patent Landscape Awareness: Continuous monitoring of prior art and related patents ensures strategic positioning.
• Innovation Strength: A broad independent claim combined with narrow dependent claims enhances robustness.
• Global Strategy: Leveraging international filings can extend protection beyond Argentina.
• Legal Vigilance: Ongoing review of potential patent challenges is essential for maintaining patent integrity.

---

FAQs

1. How does AR042543 compare with other patents in the same therapeutic area?
It depends on claim breadth and novelty. A comprehensive patent landscape analysis reveals whether it covers unique compounds or formulations not previously disclosed.

2. Can a generics manufacturer challenge the validity of AR042543?
Yes. They can file a patent opposition or invalidation proceeding based on prior art disclosures, lack of inventive step, or insufficient disclosure.

3. What is the typical patent lifespan for pharmaceuticals in Argentina?
Standard protective term is 20 years from the filing date, contingent on maintenance payments.

4. How does claim scope influence enforcement?
Broader claims allow expansive enforcement, but overly broad claims risk invalidation. Narrow claims may offer less protection but are easier to defend.

5. Is it advantageous to pursue international patent protection for inventions filed in Argentina?
Yes, especially via PCT applications, allowing for regional or global patent grants, thus maximizing commercial value.

---

References

Last updated: August 8, 2025

[1] Argentine Patent Law (Law 24,481).
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] Argentine Patent Office (INPI). Patent Search Database.